nach oben

Erschienen in:

01.11.2016 | News item

Risk of liver inflammation with TNF-α inhibitors

Einloggen, um Zugang zu erhalten

Excerpt

There is a risk of liver inflammation (autoimmune hepatitis) following treatment with TNF-α inhibitors, says Health Canada. …

Health Canada. Summary Safety Review - Tumour Necrosis Factor (TNF) alpha blockers (SIMPONI and CIMZIA) - Assessing the Potential Risk of Liver Inflammation (Autoimmune Hepatitis). Internet Document : 25 Oct 2016. Available from: URL: http://www.hc-sc.gc.ca/dhp-mps/medeff/reviews-examens/tnf-fnt-2-eng.php

Titel: Risk of liver inflammation with TNF-α inhibitors
Publikationsdatum: 01.11.2016
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2016
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-016-22750-9